COVID-19 SARS-CoV-2 Screening Protocol
NCT04740320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2024-08-13
Summary
The aim of this screening protocol is to assess volunteers for their potential eligibility to participate in a dose finding human experimental infection study in healthy subjects using a GMP-produced SARS-CoV-2 wild type strain
Conditions
- Covid19
Sponsors & Collaborators
-
Hvivo
collaborator INDUSTRY -
Imperial College London
lead OTHER
Principal Investigators
-
Chris Chiu · Imperial College London
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-12-15
- Primary Completion
- 2021-06-23
- Completion
- 2021-07-09
Countries
- United Kingdom
Study Locations
More Related Trials
-
POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test
NCT04981769 ·Status: UNKNOWN
-
SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)
NCT04750356 ·Status: UNKNOWN
-
An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia
NCT05621993 ·Status: UNKNOWN
-
SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY
NCT04784403 ·Status: COMPLETED
-
Study for Novel Coronavirus Pneumonia (NCP)
NCT04283396 ·Status: UNKNOWN
-
COVID-19 Contact Study by Antigen Detection Test
NCT04745533 ·Status: WITHDRAWN
-
Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers
NCT04370119 ·Status: COMPLETED
-
An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120
NCT04814914 ·Status: COMPLETED
-
Sensitivity Evaluation of Serological Tests for Covid-19
NCT04678024 ·Status: UNKNOWN
-
Respiratory Aerosols in Patients With COVID-19 and Healthy Controls
NCT04739020 ·Status: UNKNOWN ·Phase: NA
-
Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: "Proof of Concept" Study (CoviDetectionDog)-Covid-19
NCT04970563 ·Status: COMPLETED ·Phase: NA
-
Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting
NCT01687816 ·Status: UNKNOWN
-
Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study
NCT04508556 ·Status: COMPLETED
-
Volatile Organic Compounds Analysis by PTR-TOF-MS for Screening Respiratory Infections Using Exhaled Breath.
NCT07348380 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
NCT04333589 ·Status: UNKNOWN ·Phase: NA
-
Health Professional Exposure Assessment to Covid-19
NCT04429724 ·Status: COMPLETED ·Phase: NA
-
Long-Term Experience and Health Effects of COVID-19
NCT04477902 ·Status: COMPLETED
-
Developement and Evaluation of Serological Assays for COVID-19
NCT04377763 ·Status: UNKNOWN
-
SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings
NCT06191393 ·Status: COMPLETED ·Phase: NA
-
Glucocorticoids in COVID-19 (CORTIVID)
NCT04438980 ·Status: COMPLETED ·Phase: PHASE3
-
Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures
NCT03744728 ·Status: UNKNOWN ·Phase: NA
-
Communities Fighting COVID-19!
NCT05148936 ·Status: COMPLETED ·Phase: NA
-
Covid-19 Breath Test
NCT04459962 ·Status: COMPLETED ·Phase: NA
-
Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection
NCT04451577 ·Status: UNKNOWN
-
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
NCT01917461 ·Status: COMPLETED